Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, QurAlis is raising $60,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kasper Roet played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Navitor Pharmaceuticals is raising $20,186,771.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Thomas Hughes played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Compt Inc. is raising $2,495,000.00 in new funding. Sources indicate as part of senior management President, Amy Spurling played a key role…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Volta Networks is raising $18,877,727.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Dean Bogdanovic played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Apnimed is raising $15,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Lawrence Miller played…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Rational Vaccines is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Agustin Fernandez played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Elicio Therapeutics is raising $8,411,801.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Robert Connelly played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Swoop.com is raising $3,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ron Elwell played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Immuneering is raising $20,000,003.00 in new funding. Sources indicate as part of senior management President, Benjamin Zeskind played a key role in…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Checkmate Pharmaceuticals is raising $15,999,999.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Barry Labinger played a…